Press Releases
October 25, 2021
New data confirms long-term efficacy and safety of Emcitate® in MCT8 deficiency patients
October 8, 2021
Egetis Therapeutics receives FDA Fast Track Designation for Emcitate® for MCT8 deficiency
September 29, 2021
Egetis Therapeutics launches disease awareness initiatives to support diagnosis of MCT8 deficiency
Upcoming event
November 1, 2021
Latest presentation
September 30
Latest Report
August 19, 2021
March 30, 2021
Calendar and upcoming reports
November 4, 2021
Interim report July-September
November 11, 2021
Redeye Life Science Day 2021
November 24-25, 2021
Nordea Virtual Innovation Seminar 2021
November 30, 2021
ABG Nordic Seminar
